Long-term experience of hyperbaric oxygen therapy for refractory radio- or chemotherapy-induced haemorrhagic cystitis. | Canada Hyperbarics Skip to main content
Retrospective Study BMC urology 2015

Long-term experience of hyperbaric oxygen therapy for refractory radio- or chemotherapy-induced haemorrhagic cystitis.

Degener S, Pohle A, Strelow H, Mathers MJ, Zumbé J, Roth S, et al. — BMC urology, 2015

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers retrospectively reviewed 15 patients with refractory radio- or chemotherapy-induced haemorrhagic cystitis to evaluate the long-term effectiveness of hyperbaric oxygen therapy.

What They Found

Among 15 patients who received a median of 34 hyperbaric oxygen treatments, 80% experienced complete resolution of haemorrhagic cystitis after a median follow-up of 68 months. Two patients suffered a singular new minor haematuria (p < 0.00001).

What This Means for Canadian Patients

For Canadian patients experiencing severe haemorrhagic cystitis resistant to conventional treatments, hyperbaric oxygen therapy may offer a highly effective long-term solution. This treatment could significantly improve quality of life by resolving persistent bleeding.

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

The retrospective design and small sample size of 15 patients limit the generalizability and strength of evidence from this study.

Was this summary helpful?

Study Details

Study Type Retrospective Study
Category Radiation Injury
Source Pubmed
PubMed ID 25953493
Year Published 2015
Journal BMC urology
MeSH Terms Adult; Age Factors; Aged; Chemoradiotherapy; Cohort Studies; Cyclophosphamide; Cystitis; Female; Follow-Up Studies; Hematuria; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Quality of Life

Cite This Study

Share

Find a Canadian Clinic Treating Radiation Injury

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.